MDS 2022 | Wearable technology in Parkinson’s disease

Esther Cubo Delgado, MD, PhD, FAAN, Hospital General Yague, Burgos, Spain, discusses the growing interest in objectively measuring disease-related outcomes using wearable devices. Wearable technology has the potential to measure motor and non-motor symptoms of Parkinson’s disease. Although these platforms can provide personally and clinically meaningful endpoints and milestones to inform advances in research, including in clinical trials, there isn’t a gold standard of the best definition for these wearable technology measurements. This interview took place at the 2022 International Congress of Parkinson’s Disease and Movement Disorders in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.